Proteome-wide identification of SUMO2 modification sites

Science Signaling

Volumn 7, Issue 323, 2014, Pages

  Tammsalu, Triin ^a   Matic, Ivan ^a,b   Jaffray, Ellis G ^a   Ibrahim, Adel F M ^a   Tatham, Michael H ^a   Hay, Ronald T ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b MAX PLANCK INSTITUTE FOR BIOLOGY OF AGEING   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LYSINE; POLYHISTIDINE; SUMO 2 PROTEIN; HISTIDINE; PEPTIDE; PROTEOME; SUMO PROTEIN; SUMO2 PROTEIN, HUMAN; THREONINE;

ARTICLE; CELL CYCLE; CELL LYSATE; CONJUGATION; CONTROLLED STUDY; DNA REPAIR; EMBRYO; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; SUMOYLATION; AMINO ACID SEQUENCE; GENETICS; HEK293 CELL LINE; METABOLISM; MOLECULAR GENETICS; MUTATION; PROCEDURES; PROTEIN PROCESSING; PROTEOMICS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; BLOTTING, WESTERN; HEK293 CELLS; HISTIDINE; HUMANS; LYSINE; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOME; PROTEOMICS; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMOYLATION; THREONINE;

EID: 84899759007     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2005146     Document Type: Article

References (60)

1. R. Geiss-Friedlander, F. Melchior, Concepts in sumoylation: A decade on. Nat. Rev. Mol. Cell Biol. 8, 947-956 (2007).
2. K. Nacerddine, F. Lehembre, M. Bhaumik, J. Artus, M. Cohen-Tannoudji, C. Babinet, P. P. Pandolfi, A. Dejean, The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Dev. Cell 9, 769-779 (2005).
3. H. Saitoh, J. Hinchey, Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J. Biol. Chem. 275, 6252-6258 (2000).
4. F. Golebiowski, I. Matic, M. H. Tatham, C. Cole, Y. Yin, A. Nakamura, J. Cox, G. J. Barton, M. Mann, R. T. Hay, System-wide changes to SUMO modifications in response to heat shock. Sci. Signal. 2, ra24 (2009).
5. J. Schimmel, K. M. Larsen, I. Matic, M. van Hagen, J. Cox, M. Mann, J. S. Andersen, A. C. Vertegaal, The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle. Mol. Cell. Proteomics 7, 2107-2122 (2008).
6. M. H. Tatham, I. Matic, M. Mann, R. T. Hay, Comparative proteomic analysis identifies a role for SUMO in protein quality control. Sci. Signal. 4, rs4 (2011).
7. Y. Galanty, R. Belotserkovskaya, J. Coates, S. Polo, K. M. Miller, S. P. Jackson, Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks. Nature 462, 935-939 (2009).
8. J. R. Morris, C. Boutell, M. Keppler, R. Densham, D. Weekes, A. Alamshah, L. Butler, Y. Galanty, L. Pangon, T. Kiuchi, T. Ng, E. Solomon, The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Nature 462, 886-890 (2009).
9. R. T. Hay, SUMO: A history of modification. Mol. Cell 18, 1-12 (2005).
10. M. H. Tatham, E. Jaffray, O. A. Vaughan, J. M. Desterro, C. H. Botting, J. H. Naismith, R. T. Hay, Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J. Biol. Chem. 276, 35368-35374 (2001).
11. I. Matic, M. van Hagen, J. Schimmel, B. Macek, S. C. Ogg, M. H. Tatham, R. T. Hay, A. I. Lamond, M. Mann, A. C. Vertegaal, In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy. Mol. Cell. Proteomics 7, 132-144 (2008).
12. M. H. Tatham, M. C. Geoffroy, L. Shen, A. Plechanovova, N. Hattersley, E. G. Jaffray, J. J. Palvimo, R. T. Hay, RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat. Cell Biol. 10, 538-546 (2008).
13. V. Lallemand-Breitenbach, M. Jeanne, S. Benhenda, R. Nasr, M. Lei, L. Peres, J. Zhou, J. Zhu, B. Raught, H. de Thé, Arsenic degrades PML or PML-RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat. Cell Biol. 10, 547-555 (2008).
14. A. Pichler, A. Gast, J. S. Seeler, A. Dejean, F. Melchior, The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108, 109-120 (2002).
15. D. Reverter, C. D. Lima, Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex. Nature 435, 687-692 (2005).
16. R. T. Hay, SUMO-specific proteases: A twist in the tail. Trends Cell Biol. 17, 370-376 (2007).
17. G. Filosa, S. M. Barabino, A. Bachi, Proteomics strategies to identify SUMO targets and acceptor sites: A survey of RNA-binding proteins SUMOylation. Neuromolecular Med. 15, 661-676 (2013).
18. 6-HA-SUMO1 knock-in mice. Proc. Natl. Acad. Sci. U.S.A. 109, 21122-21127 (2012).
19. A. C. Vertegaal, J. S. Andersen, S. C. Ogg, R. T. Hay, M. Mann, A. I. Lamond, Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics. Mol. Cell. Proteomics 5, 2298-2310 (2006).
20. V. Matafora, A. D'Amato, S. Mori, F. Blasi, A. Bachi, Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition. Mol. Cell. Proteomics 8, 2243-2255 (2009).
21. J. Becker, S. V. Barysch, S. Karaca, C. Dittner, H. H. Hsiao, M. Berriel Diaz, S. Herzig, H. Urlaub, F. Melchior, Detecting endogenous SUMO targets in mammalian cells and tissues. Nat. Struct. Mol. Biol. 20, 525-531 (2013).
22. R. Bruderer, M. H. Tatham, A. Plechanovova, I. Matic, A. K. Garg, R. T. Hay, Purification and identification of endogenous polySUMO conjugates. EMBORep. 12, 142-148 (2011).
23. C. Choudhary, C. Kumar, F. Gnad, M. L. Nielsen, M. Rehman, T. C. Walther, J. V. Olsen, M. Mann, Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-840 (2009).
24. J. V. Olsen, B. Blagoev, F. Gnad, B. Macek, C. Kumar, P. Mortensen, M. Mann, Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127, 635-648 (2006).
25. G. Xu, J. S. Paige, S. R. Jaffrey, Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling. Nat. Biotechnol. 28, 868-873 (2010).
26. W. Kim, E. J. Bennett, E. L. Huttlin, A. Guo, J. Li, A. Possemato, M. E. Sowa, R. Rad, J. Rush, M. J. Comb, J. W. Harper, S. P. Gygi, Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol. Cell 44, 325-340 (2011).
27. S. A. Wagner, P. Beli, B. T. Weinert, M. L. Nielsen, J. Cox, M. Mann, C. Choudhary, A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol. Cell. Proteomics 10, M111 013284 (2011).
28. P. G. Pedrioli, B. Raught, X. D. Zhang, R. Rogers, J. Aitchison, M. Matunis, R. Aebersold, Automated identification of SUMOylation sites using mass spectrometry and SUMmOn pattern recognition software. Nat. Methods 3, 533-539 (2006).
29. I. Matic, J. Schimmel, I. A. Hendriks, M. A. van Santen, F. van de Rijke, H. van Dam, F. Gnad, M. Mann, A. C. Vertegaal, Site-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif. Mol. Cell 39, 641-652 (2010).
30. H. H. Hsiao, E. Meulmeester, B. T. Frank, F. Melchior, H. Urlaub, "ChopNSpice" a mass spectrometric approach that allows identification of endogenous small ubiquitin-like modifier-conjugated peptides. Mol. Cell. Proteomics 8, 2664-2675 (2009).
31. T. Makhnevych, Y. Sydorskyy, X. Xin, T. Srikumar, F. J. Vizeacoumar, S. M. Jeram, Z. Li, S. Bahr, B. J. Andrews, C. Boone, B. Raught, Global map of SUMO function revealed by protein-protein interaction and genetic networks. Mol. Cell 33, 124-135 (2009).
32. M. Knuesel, H. T. Cheung, M. Hamady, K. K. Barthel, X. Liu, A method of mapping protein sumoylation sites by mass spectrometry using a modified small ubiquitin-like modifier 1 (SUMO-1) and a computational program. Mol. Cell. Proteomics 4, 1626-1636 (2005).
33. H. A. Blomster, S. Y. Imanishi, J. Siimes, J. Kastu, N. A. Morrice, J. E. Eriksson, L. Sistonen, In vivo identification of sumoylation sites by a signature tag and cysteine-targeted affinity purification. J. Biol. Chem. 285, 19324-19329 (2010).
34. P. V. Hornbeck, J. M. Kornhauser, S. Tkachev, B. Zhang, E. Skrzypek, B. Murray, V. Latham, M. Sullivan, PhosphoSitePlus: A comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res. 40, D261-D270 (2012).
35. M. S. Rodriguez, C. Dargemont, R. T. Hay, SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276, 12654-12659 (2001).
36. J. P. O'Shea, M. F. Chou, S. A. Quader, J. K. Ryan, G. M. Church, D. Schwartz, pLogo: A probabilistic approach to visualizing sequence motifs. Nat. Methods 10, 1211-1212 (2013).
37. J. M. Desterro, M. S. Rodriguez, G. D. Kemp, R. T. Hay, Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1. J. Biol. Chem. 274, 10618-10624 (1999).
38. E. S. Johnson, G. Blobel, Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p. J. Biol. Chem. 272, 26799-26802 (1997).
39. U. Karvonen, T. Jääskeläinen, M. Rytinki, S. Kaikkonen, J. J. Palvimo, ZNF451 is a novel PML body- and SUMO-associated transcriptional coregulator. J. Mol. Biol. 382, 585-600 (2008).
40. S. Chupreta, H. Brevig, L. Bai, J. L. Merchant, J. A. Iñiguez-Lluhí, Sumoylation-dependent control of homotypic and heterotypic synergy by the Kruppel-type zinc finger protein ZBP-89. J. Biol. Chem. 282, 36155-36166 (2007).
41. M. T. Vassileva, M. J. Matunis, SUMO modification of heterogeneous nuclear ribonucleoproteins. Mol. Cell. Biol. 24, 3623-3632 (2004).
42. P. Mertins, J. W. Qiao, J. Patel, N. D. Udeshi, K. R. Clauser, D. R. Mani, M. W. Burgess, M. A. Gillette, J. D. Jaffe, S. A. Carr, Integrated proteomic analysis of post-translational modifications by serial enrichment. Nat. Methods 10, 634-637 (2013).
43. Ø. Dahle, T. Ø. Andersen, O. Nordgård, V. Matre, G. Del Sal, O. S. Gabrielsen, Transactivation properties of c-Myb are critically dependent on two SUMO-1 acceptor sites that are conjugated in a PIASy enhanced manner. Eur. J. Biochem. 270, 1338-1348 (2003).
44. J. Bies, J. Markus, L. Wolff, Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity. J. Biol. Chem. 277, 8999-9009 (2002).
45. C. Weber, T. B. Schreiber, H. Daub, Dual phosphoproteomics and chemical proteomics analysis of erlotinib and gefitinib interference in acute myeloid leukemia cells. J. Proteomics 75, 1343-1356 (2012).
46. C. Choudhary, M. Mann, Decoding signalling networks by mass spectrometry-based proteomics. Nat. Rev. Mol. Cell Biol. 11, 427-439 (2010).
47. E. Pani, M. Menigatti, S. Schubert, D. Hess, B. Gerrits, K. H. Klempnauer, S. Ferrari, Pin1 interacts with c-Myb in a phosphorylation-dependent manner and regulates its transactivation activity. Biochim. Biophys. Acta 1783, 1121-1128 (2008).
48. H. A. Blomster, V. Hietakangas, J. Wu, P. Kouvonen, S. Hautaniemi, L. Sistonen, Novel proteomics strategy brings insight into the prevalence of SUMO-2 target sites. Mol. Cell. Proteomics 8, 1382-1390 (2009).
49. H. J. Cooper, M. H. Tatham, E. Jaffray, J. K. Heath, T. T. Lam, A. G. Marshall, R. T. Hay, Fourier transform ion cyclotron resonance mass spectrometry for the analysis of small ubiquitin-like modifier (SUMO) modification: Identification of lysines in RanBP2 and SUMO targeted for modification during the E3 autoSUMOylation reaction. Anal. Chem. 77, 6310-6319 (2005).
50. I. Psakhye, S. Jentsch, Protein group modification and synergy in the SUMO pathway as exemplified in DNA repair. Cell 151, 807-820 (2012).
51. S. Hobbs, S. Jitrapakdee, J. C. Wallace, Development of a bicistronic vector driven by the human polypeptide chain elongation factor 1α promoter for creation of stable mammalian cell lines that express very high levels of recombinant proteins. Biochem. Biophys. Res. Commun. 252, 368-372 (1998).
52. M. H. Tatham, M. S. Rodriguez, D. P. Xirodimas, R. T. Hay, Detection of protein SUMOylation in vivo. Nat. Protoc. 4, 1363- 1371 (2009).
53. J. R. Wiśniewski, A. Zougman, N. Nagaraj, M. Mann, Universal sample preparation method for proteome analysis. Nat. Methods 6, 359-362 (2009).
54. N. D. Udeshi, P. Mertins, T. Svinkina, S. A. Carr, Large-scale identification of ubiquitination sites by mass spectrometry. Nat. Protoc. 8, 1950-1960 (2013).
55. J. Rappsilber, M. Mann, Y. Ishihama, Protocol for micro-purification, enrichment, prefractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2, 1896-1906 (2007).
56. J. Cox, M. Mann, MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367-1372 (2008).
57. J. Cox, N. Neuhauser, A. Michalski, R. A. Scheltema, J. V. Olsen, M. Mann, Andromeda: A peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 10, 1794-1805 (2011).
58. N. Neuhauser, A. Michalski, J. Cox, M. Mann, Expert system for computer-assisted annotation of MS/MS spectra. Mol. Cell. Proteomics 11, 1500-1509 (2012).
59. L. Shen, M. H. Tatham, C. Dong, A. Zagórska, J. H. Naismith, R. T. Hay, SUMO protease SENP1 induces isomerization of the scissile peptide bond. Nat. Struct. Mol. Biol. 13, 1069-1077 (2006).
60. A. Shevchenko, H. Tomas, J. Havlis, J. V.Olsen, M. Mann, In-gel digestion formass spectrometric characterization of proteins and proteomes. Nat. Protoc. 1, 2856-2860 (2006).